from LQSF in proportion of 65%), a decrease of 66% YoY. EBITDA margin was 3.2%, a decrease from 9.1% in Q2/2017, mainly due to poorer operating results as earlier explained. If excluding a one-time cost

( present value) , financial position, operating results, nature of business operations, potential and opportunity for business expansion and price appraisal by financial advisor. บริษัท ดีโอดี ไบโอเทค จ ำกัด

into account various factors, such as, value of assets ( present value) , financial position, operating results, nature of business operations, potential and opportunity for business expansion and price

operation of IRPC-CP both phases. Operating Results Overall operating results of the company and its subsidiaries Overall operating results of the company and its subsidiaries Q2/17 Q1/18 Q2/18 Change

resulted from the full operation of both phases of IRPC-CP in this quarter. Operating Result Overall operating results of the company and its subsidiaries Overall operating results of the company and its

Overall operating results of the company and its subsidiaries 5 Financial Performance GPSC and its subsidiaries generated a net profit in Q3/2017 that attributed to the company for Baht 888 million. Net

1 Ref: AC.004/2018 26 February 2018 Subject: Management discussion and analysis of financial position and operating results To: President and Manager The Stock Exchange of Thailand Overall operating

1 Ref: AC.031/2017 15 August 2017 Subject: Management discussion and analysis of financial position and operating results To: President and Manager The Stock Exchange of Thailand Overall operating

Summary of Consolidated Financial Results 1. Operating Results Revenues In the fiscal year ended February 28, 2023, the total consolidated revenues were 22,332 million baht, increasing of 1,541 million baht

Government Saving Bank in Thailand. This is not only potentially decreases our funding costs but also stabilized company financial conditions. 2 Summary of Consolidated Financial Results 1. Operating Results